June 2022 in “Journal of the turkish academy of dermatology” This study from Turkey observed that the COVID-19 pandemic adversely affected dermatology patients, particularly by interrupting treatments and restricting outpatient visits.
March 2025 in “Journal of Drugs in Dermatology” This study developed a physician-guided algorithm to manage cutaneous adverse events from hormonal therapy in cancer patients, aiming to reduce treatment interruptions and enhance quality of life.
14 citations
,
September 2003 in “Archives of Dermatology” This abstract provides no new data or findings as it is a placeholder text rather than a research summary.
September 2025 in “Australasian Journal of Dermatology” In this update, researchers incorporated TGA-approved Janus Kinase inhibitors into the Australian treatment guidelines for chronic, moderate to severe Alopecia areata, aiming to enhance recommended therapies by providing guidance on the use and management of these systemic medications.
June 2016 in “Annals of the rheumatic diseases” This study found that methotrexate, when administered according to current recommendations, effectively manages rheumatoid arthritis for many patients in Poland, although regular monitoring is necessary due to possible adverse effects.
